A detailed history of Alpine Global Management, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Alpine Global Management, LLC holds 25,000 shares of AXNX stock, worth $1.77 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
25,000
Previous 25,000 -0.0%
Holding current value
$1.77 Million
Previous $1.68 Million 3.63%
% of portfolio
0.53%
Previous 0.37%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.67 - $69.36 $1.42 Million - $1.73 Million
25,000 New
25,000 $1.72 Million
Q4 2021

Feb 14, 2022

SELL
$50.01 - $73.35 $409,981 - $601,323
-8,198 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$59.21 - $78.66 $485,403 - $644,854
8,198 New
8,198 $615,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.